| 產(chǎn)品名稱(chēng) |
Human rhinovirus 60 |
| 商品貨號 |
B234005 |
| Classification |
Picornaviridae, Rhinovirus, Human rhinovirus A |
| Deposited As |
Rhinovirus 60 |
| Agent |
Human rhinovirus 60 |
| Strain |
2268-CV37 |
| Applications |
Respiratory research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
derived from ATCC VR-1170, which was contributed by NIAID (V-150-002-021), produced by Abbott Laboratories for NIH contract 71-2114 as a reseach reference agent |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder |
| Comments |
-70C or lower NIAID derived from ATCC VR-1170 |
| Effect on Host |
Yes, in vitro effects: Cytopathic effects CPE |
| Recommended Host |
HeLa cells (ATCC CCL-2) Host of Choice: HeLa cells WI-38 cells (ATCC CCL-75); HeLa cells (ATCC CCL-2); other monkey and human cell lines |
| Growth Conditions |
Duration: 1-7 days at 33C in HeLa cells (ATCC CCL-2), rocking |
| Cryopreservation |
Storage temperature: -70C or lower |
| Name of Depositor |
NIAID |
| Special Collection |
NCRR Contract |
| Source |
derived from ATCC VR-1170, which was contributed by NIAID (V-150-002-021), produced by Abbott Laboratories for NIH contract 71-2114 as a reseach reference agent |
| References |
Couch RBChapter 22: RhinovirusesIn: Couch RBVirology, 2nd ed.New York, NYRaven Press1990.
|
